# Nerivio Efficacy by Time of Treatment Onset

> **NCT06976723** · PHASE4 · COMPLETED · sponsor: **Theranica** · enrollment: 55261 (actual)

## Conditions studied

- Migraine
- Acute Treatment of Migraine

## Interventions

- **DEVICE:** Nerivio

## Key facts

- **NCT ID:** NCT06976723
- **Lead sponsor:** Theranica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-07
- **Primary completion:** 2025-06-10
- **Final completion:** 2025-06-15
- **Target enrollment:** 55261 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976723, "Nerivio Efficacy by Time of Treatment Onset". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06976723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*